Literature DB >> 21739465

Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts.

Shengqiang Yu1, Chiuan-Ren Yeh, Yuanjie Niu, Hong-Chiang Chang, Yu-Chieh Tsai, Harold L Moses, Chih-Rong Shyr, Chawnshang Chang, Shuyuan Yeh.   

Abstract

BACKGROUND: Androgens and the androgen receptor (AR) play important roles in the development of male urogenital organs. We previously found that mice with total AR knockout (ARKO) and epithelial ARKO failed to develop normal prostate with loss of differentiation. We have recently knocked out AR gene in smooth muscle cells and found the reduced luminal infolding and IGF-1 production in the mouse prostate. However, AR roles of stromal fibroblasts in prostate development remain unclear.
METHODS: To further probe the stromal fibroblast AR roles in prostate development, we generated tissue-selective knockout mice with the AR gene deleted in stromal fibroblasts (FSP-ARKO). We also used primary culture stromal cells to confirm the in vivo data and investigate mechanisms related to prostate development.
RESULTS: The results showed cellular alterations in the FSP-ARKO mouse prostate with decreased epithelial proliferation, increased apoptosis, and decreased collagen composition. Further mechanistic studies demonstrated that FSP-ARKO mice have defects in the expression of prostate stromal growth factors. To further confirm these in vivo findings, we prepared primary cultured mouse prostate stromal cells and found knocking down the stromal AR could result in growth retardation of prostate stromal cells and co-cultured prostate epithelial cells, as well as decrease of some stromal growth factors.
CONCLUSIONS: Our FSP-ARKO mice not only provide the first in vivo evidence in Cre-loxP knockout system for the requirement of stromal fibroblast AR to maintain the normal development of the prostate, but may also suggest the selective knockdown of stromal AR might become a potential therapeutic approach to battle prostate hyperplasia and cancer.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739465      PMCID: PMC4402036          DOI: 10.1002/pros.21445

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  49 in total

Review 1.  Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors.

Authors:  G R Cunha; E T Alarid; T Turner; A A Donjacour; E L Boutin; B A Foster
Journal:  J Androl       Date:  1992 Nov-Dec

2.  Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer.

Authors:  P N Mainwaring; P A Ellis; S Detre; I E Smith; M Dowsett
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

3.  The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice.

Authors:  G R Cunha; B Lung
Journal:  J Exp Zool       Date:  1978-08

4.  A modification of the Masson-trichrome stain.

Authors:  I Singh
Journal:  Indian J Pathol Bacteriol       Date:  1969-10

5.  Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells.

Authors:  Caixia Zhang; Shuyuan Yeh; Yen-Ta Chen; Cheng-Chia Wu; Kuang-Hsiang Chuang; Hung-Yun Lin; Ruey-Sheng Wang; Yu-Jia Chang; Chamindrani Mendis-Handagama; Liquan Hu; Henry Lardy; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-09       Impact factor: 11.205

Review 6.  Androgen insensitivity syndrome: clinical features and molecular defects.

Authors:  Angeliki Galani; Sophia Kitsiou-Tzeli; Christalena Sofokleous; Emmanuel Kanavakis; Ariadni Kalpini-Mavrou
Journal:  Hormones (Athens)       Date:  2008 Jul-Sep       Impact factor: 2.885

7.  Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

Authors:  Mingfang Ao; Omar E Franco; Dean Park; Dayanidhi Raman; Karin Williams; Simon W Hayward
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Sex steroid-induced changes in collagen of the prostate and seminal vesicle of rats.

Authors:  N Srinivasan; M M Aruldhas; P Govindarajulu
Journal:  J Androl       Date:  1986 Jan-Feb

9.  Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.

Authors:  Chun-Te Wu; Saleh Altuwaijri; William A Ricke; Shu-Pin Huang; Shuyuan Yeh; Caixia Zhang; Yuanjie Niu; Meng-Ying Tsai; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-25       Impact factor: 11.205

10.  Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.

Authors:  Yuanjie Niu; Saleh Altuwaijri; Shuyuan Yeh; Kuo-Pao Lai; Shengqiang Yu; Kuang-Hsiang Chuang; Shu-Pin Huang; Henry Lardy; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

View more
  30 in total

1.  Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.

Authors:  Chun-Peng Liao; Leng-Ying Chen; Andrea Luethy; Youngsoo Kim; Kian Kani; A Robert MacLeod; Mitchell E Gross
Journal:  Endocr Relat Cancer       Date:  2017-04       Impact factor: 5.678

Review 2.  The reactive stroma microenvironment and prostate cancer progression.

Authors:  David A Barron; David R Rowley
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

3.  Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy.

Authors:  Kuo-Pao Lai; Jiann-Jyh Lai; Philip Chang; Saleh Altuwaijri; Jong-Wei Hsu; Kuang-Hsiang Chuang; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2012-12-18

4.  Reduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor α knockout mice.

Authors:  Ming Chen; Chiuan-Ren Yeh; Chih-Rong Shyr; Hsiu-Hsia Lin; Jun Da; Shuyuan Yeh
Journal:  Asian J Androl       Date:  2012-05-21       Impact factor: 3.285

5.  Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor.

Authors:  Kuo-Pao Lai; Shinichi Yamashita; Spencer Vitkus; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2011-12-01

Review 6.  Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.

Authors:  Simeng Wen; Hong-Chiang Chang; Jing Tian; Zhiqun Shang; Yuanjie Niu; Chawnshang Chang
Journal:  Am J Pathol       Date:  2014-11-26       Impact factor: 4.307

Review 7.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

8.  Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR.

Authors:  Chiung-Kuei Huang; Meng-Yin Tsai; Jie Luo; Hong-Yo Kang; Soo Ok Lee; Chawnshang Chang
Journal:  Biochim Biophys Acta       Date:  2013-01-17

9.  Spatiotemporal dynamics of androgen signaling underlie sexual differentiation and congenital malformations of the urethra and vagina.

Authors:  Christine E Larkins; Ana B Enriquez; Martin J Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 10.  Stromal androgen receptor in prostate development and cancer.

Authors:  Mandeep Singh; Ruchi Jha; Jonathan Melamed; Ellen Shapiro; Simon W Hayward; Peng Lee
Journal:  Am J Pathol       Date:  2014-08-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.